About the Author

Calan Smith
Head of Animal Health Portfolio at Kisaco Research for the last 5 years, Calan has developed the global investment partnering event series to become an industry standard and must attend for leadership teams around the globe, including start-ups, investors and multinationals.
With the primary responsibility for developing and driving an industry agenda that supports growth and innovation, most recently Calan and Kisaco have broadened the scope of our market intelligence offering to include both an international event series and a business intelligence reports.
- 
                    MotivationThe animal health industry in 2020 is experiencing a tectonic shift. While still feeling the lingering effects of the African Swine Fever virus, the industry is now faced with the personal and professional impact of a global COVID-19 pandemic, as well as a societal awakening in light of recent events in the United States, leading to the Black Lives Matter movement. The result has been an unprecedented level of accelerated change within the industry, leading to new directions and scenarios that we have outlined in this report. As we started this process one thing became abundantly clear and that was the importance and growth in the veterinary telemedicine business. This has become a critical delivery method for veterinarians during the outbreak and regulations have been eased to enable the technology to be implemented, causing years’ worth of growth and accelerated adoption for the industries top providers. However, key questions remain around the opportunity for remote prescription and the approach to the technology post-COVID. We have therefore dedicated a significant portion of this report to addressing telemedicine and have interviewed the world’s leading authorities on the subject. 
- 
                      ContentsForeword 3 Report Summary 5 Emerging Areas of Interest in Animal Health due to COVID-19: 5 Our Predictions 6 Headline points per chapter 8 Telemedicine 8 Geographies 9 Large Animal Health Companies 10 Start Ups 10 Investors 11 Veterinarians 11 CROs, Large Corporates, and Associations 12 Introduction 13 Telehealth in the Veterinary Industry 14 Customer Adoption of Telemedicine 15 Investors and Telemedicine 17 Large Corporates, Associations, and Telemedicine 18 The Veterinary Profession and Telemedicine 19 Defining “Under our Care” for Telemedicine 21 Veterinary Telemedicine Around the World 22 Telemedicine in China 22 Telemedicine in Brazil 23 Telemedicine in Japan 23 Geographic Impact of COVID-19 in Animal Health 24 Impacts on China 25 Trends and Positive Outcomes 26 African Swine Fever Update 27 Breaking into the Chinese Market 27 Impacts on Brazil 28 Trends and Positive Outcomes 28 Impacts of ASF in Brazil 29 Impacts in Japan 30 Manufacturing Dependencies 30 Trends and Positive Outcomes 31 Emerging Infectious Diseases in Japan 31 Breaking into the Japanese Market 32 The Investor Perspective on Covid-19 33 The Next Era of Innovation 34 Investing Appetite 34 Investment strategy 35 Investor Concerns 37 Start Up Etiquette 38 Meat Processing 39 Food Delivery Service Model 39 Shifting Interest in Innovations 40 Labor Shortages and Skills Gap 41 Sustainability 42 Deal Flow 42 New Features in Start Ups 43 Key Insights 43 Impacts on Startups 44 Startup Challenges and Pivot Points 44 Planning is Key 46 COVID-19 Related Funds and Loans in US and UK 46 Response and Impact to the Large Animal Health Companies 47 Impacts on Business Operations 48 Integration of Technology 48 Innovation in Livestock and Companion Animals 49 Lessons Learned from COVID-19 50 E-Commerce 51 Pandemic Preparations with POC Diagnostics 51 Top Priorities in the Next 6-12 Months 52 Large Animal Health Companies’ COVID-19 Responses 53 Bayer Animal Health 53 Boehringer Ingelheim 53 Ceva Sante Animale 53 Elanco Animal Health 53 IDEXX 53 Merck 53 Phibro Animal Health 53 Vetoquinol 53 Virbac 53 Zenoaq 53 Zoetis 53 Impacts of CRO’s, Animal Health Associations, Government Agencies, and Large Corporates 54 Responses from Large Organizations 55 Labor Shortages and Skills gap from COVID and Brexit 56 Food Protectionism 57 Manufacturing and Regulatory 57 Pet Adoption 58 Large Animal Health Companies and Large Veterinary Corporates 58 Preventative Products 59 Recovery, One Health, and Sustainability 59 Increase in Nationalism 60 Roadmap of Lockdown Measures and Impact to Clinics 61 Lessons Learned 62 Pet Owner Concerns and Routine Care 63 Impact of COVID-19 on the Veterinary Industry 64 The Veterinary Industry During COVID-19 64 Pandemic Puppies and Corona Kitten Adoptions 65 Production Animal vs. Companion Animal Veterinarians and Technology 66 Change in Business Model from Veterinary Products to Veterinary Services 67 Working Conditions for Veterinarians during COVID-19 68 Impact of COVID-19 on Working Women Veterinarians 69 Pet Owner Concerns 70 
- 
                      Emerging Areas of InterestEmerging Areas of Interest in Animal Health due to COVID-19: • Labor shortages • Skills gap • Telemedicine • Renewal of old vaccine platforms • Automation • Point of care diagnostics • Nationalism • Manufacturing dependencies • Effective scientific communication • One health policy development • Sustainability • Integration of technology into practices and companies • Animal health recovery is faster than predicted • Education of pet owners to value veterinarian care • Veterinarian business model changing from selling products to services • Precision livestock farming Food supply sustainability • Veterinary medicine inventory and sustainability • Increase investment in robotics and automation (R&A) for livestock • Food protectionism • Food supply waste • Shortening of the supply chain • Investors focusing on portfolio companies • Pet insurance merging with telehealth offerings • COVID as a catalyst for existing trends • One health diagnostics • Demand for preventative products and alternative medicines • Food transparency • Safety and traceability • Resiliency strategies from small to large • E-commerce 
- 
                  About the Author Calan SmithDirector - Animal Health PortfolioKisaco ResearchHead of Animal Health Portfolio at Kisaco Research for the last 5 years, Calan has developed the global investment partnering event series to become an industry standard and must attend for leadership teams around the globe, including start-ups, investors and multinationals. With the primary responsibility for developing and driving an industry agenda that supports growth and innovation, most recently Calan and Kisaco have broadened the scope of our market intelligence offering to include both an international event series and a business intelligence reports. 
Request a sample
Please complete the form below to receive a sample of this report.
Purchase the report
Single User | $2,499 | Buy Online
Company-wide Use (Private Company) | $4,999 | Buy Online
Company-wide Use (Listed Company) | $7,499 | Buy Online
VAT will be added for companies based in the UK. For further information or support in purchasing a report, please email:
[email protected]